{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-21-125849","form_type":"8-K","ticker":"BTAI","cik":"0001720893","company_name":"BioXcel Therapeutics, Inc.","filed_at":"2021-10-13T23:59:59+00:00","discovered_at":"2026-05-14T18:04:13.827817+00:00","generated_at":"2026-06-28T21:09:55.888314+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"negative","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"BioXcel Therapeutics EVP & Chief Commercial Officer William P. Kane resigns effective immediately","bullets":["William P. Kane, Jr., EVP and Chief Commercial Officer, resigned on October 8, 2021, effective immediately.","No reason for the resignation was provided in the filing.","No successor or interim appointment has been announced."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-21-125849","json":"https://secwatch.observer/filing/0001104659-21-125849.json","markdown":"https://secwatch.observer/filing/0001104659-21-125849.md","text":"https://secwatch.observer/filing/0001104659-21-125849.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1720893/000110465921125849/0001104659-21-125849-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1720893/000110465921125849/tm2129371d2_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T21:09:55.888314+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"7f6956bea2","claim":"William P. Kane, Jr. resigned as Executive Vice President and Chief Commercial Officer at BioXcel Therapeutics, Inc..","evidence_excerpt":"On October 8, 2021, William P. Kane, Jr., Executive Vice President and Chief Commercial Officer of BioXcel Therapeutics, Inc. (the “Company”) tendered his resignation notice to the Company, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1720893/000110465921125849/0001104659-21-125849-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Executive Vice President and Chief Commercial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}